Covid-19 has changed the healthcare landscape, what actions can industry partners take now to create strategic growth opportunities in 2020 and beyond? Join HMMC as we discuss the shift from inpatient-to-outpatient settings, key healthcare trends, and how this will impact the different service lines, markets, and care settings. Sg2 Life Sciences and Industry, a Vizient company, will lead us as we prepare for the future of healthcare.
Sg2 COVID-19 Update for Industry an Overview of Key Healthcare Trends
Expected to Accelerate
The Life Sciences and Industry team from Sg2, a Vizient company, will present an update on COVID-19 and guidance shared with our provider members. In addition, we’ll also focus on key healthcare trends expected to accelerate and to help industry partners understand market dynamics that could disrupt your portfolio or create new strategic growth opportunities. Join us to gain a better understanding of how the inpatient-to-outpatient shift will play out across different service lines, markets and care settings. And how trends like ‘hospital at home’ and expanded critical care capacity will play an accelerated role in health care delivery globally.
In this webinar, you will learn about:
- Sg2’s guidance to providers around COVID-19
- Sg2’s perspective on the evolving healthcare landscape and how we predict care will shift
over the next decade. - The key trends likely to accelerate in 2020 and where and how we expect them to have an
impact - What actions you need to take today to better prepare for your health system customer
needs and challenges
*Note: Due to the coronavirus pandemic, HMMC is making this webinar available to HMMC Members and Non-member medical manufacturer executives. If you find this webinar informative please consider Joining HMMC
About the Speakers
Jeffrey Moser
Principal, Sg2
As a thought leader on enterprise strategy, Jeff helps both health system and life sciences and industry clients understand the implications of emerging macro- and microlevel trends impacting health care. He plays a key role in the development of Sg2 Intelligence resources and educational offerings and is a frequent presenter and educator on multiple topics, including health care reform, consumerism and patient engagement, ambulatory strategy, value-based care, and leading practices in care redesign.
Jeff has more than 25 years of health care advisory and consulting experience, with specific areas of expertise including strategic planning, process improvement, operational effectiveness and organizational change.
Before joining Sg2, Jeff was the vice president of assessments at Cardinal Health in Dublin, OH, where he identified opportunities for improvement and recommended specific strategies to client organizations. He also led health care consulting projects focused on improving profitability, quality and service for both specific departments and entire organizations. During his tenure, Jeff helped identify opportunities that yielded an average of 12% operating improvement. In his last 5 years, he participated in or led an average of 15 assessments per year. He was integral to the development of Cardinal Health’s “patient throughput” product in 2002.
Prior to his work at Cardinal Health, Jeff served as a project director for West Hudson, Inc (now part of Cardinal Health). There, he facilitated the implementation of hospital-based quality-, service- and cost-related process improvements both inter- and intradepartmentally. Jeff received an MS in organizational psychology from Springfield College in Massachusetts and a BS with a double major in economics and psychology from Texas Christian University.
Amy Brouhle, RN, BSN, MBA, MHA
Vice President, Business Development, Sg2
As a vice president at Sg2, Amy is responsible for driving new business for Sg2 in the supplier segment of the market, which includes pharmaceutical, medical device and life science companies. She focuses on identifying emerging trends, industry disruption and partnership opportunities for life science organizations to leverage for growth, and she helps prioritize IDN segmentation and innovation. Previously at Sg2, she was accountable for growing new sales in the Western region of the United States, including California and Texas.
Amy has over 25 years of experience in the health care arena and has held positions spanning a variety of consulting, operational and clinical services. Prior to joining Sg2, she worked with Press Ganey Associates, Inc, and most recently served as vice president of ambulatory services, where she was responsible for the strategic direction, revenue growth, product development, regulatory alliance, sales messaging and marketing of the ambulatory service lines. She also managed product development and collaborated with marketing and sales as vice president of client enterprise solutions, and she provided marketplace and regulatory expertise to large medical practices seeking to grow market share as director of medical services, among other Press Ganey Associates duties and roles.
Additionally, Amy has held positions with GE Healthcare, Per-Se Technologies and the TriZetto Group, Inc. She has extensive consulting experience in medical practice start-ups, physician compensation planning and revenue cycle reengineering. She began her career as a registered nurse.
Amy holds a master of business administration and a master of health administration from the University of Colorado Denver, and she has a bachelor of science in nursing from the University of Virginia.